Westside Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-56
Closed -$116 821
2017
Q2
$116 Buy
+56
New +$3.73K ﹤0.01% 804

Other funds holding GILD

Westside Investment Management's GILD Position: Q2 2026 in Review

Westside Investment Management reduced its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, selling an estimated $34.7K and leaving 22,902 shares worth $2.89M. The position accounts for 0.38% of the portfolio, ranked #67.

Westside Investment Management first reported a position in GILD in Q4 2016 and has held it in 36 quarters since. The position peaked at $3.29M in Q3 2018. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Westside Investment Management held 22,902 shares of Gilead Sciences worth $2.89M as of Q2 2026.
  • Westside Investment Management sold 263 Gilead Sciences shares in Q2 2026, an estimated $34.7K.
  • Gilead Sciences made up 0.38% of Westside Investment Management's portfolio in Q2 2026, its #67 holding.
  • Westside Investment Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 36 quarters since.
  • Westside Investment Management's Gilead Sciences position peaked at $3.29M in Q3 2018.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.